June 12, 2000
Office of the Chief Accountant
SECPS Letter File
Securities and Exchange Commission
Mail Stop 9-5
450 Fifth Street, N.W.
Washington, D.C. 20549
RE: General Form for Registration of Securities on Amendment 4 to Form 10-SB for
Allergy Immuno Technologies, Inc.
We have read Part II, Item 3 included in Amendment 4 to Form 10-SB for Allergy
Immuno Technologies, Inc. (Commission File No. 000-26189) dated June 12, 2000 to
be filed with the Securities and Exchange Commission and are in agreement with
the statements contained therein.
/s/ CORBIN & WERTZ
CC: Ms. Janet Moore
